Aligos Therapeutics Inc
F:5WK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aligos Therapeutics Inc
F:5WK
|
US |
|
Telefonaktiebolaget LM Ericsson
BMV:ERICN
|
SE |
|
M
|
Mitsubishi Estate Co Ltd
XBER:MES
|
JP |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 5WK's stock price target?
Not Available
5WK does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Aligos Therapeutics Inc?
Projected CAGR
203%
The compound annual growth rate for Revenue over the next 3 years is 203%.